https://www.selleckchem.com/pr....oducts/jnj-64264681.
https://www.selleckchem.com/pr....oducts/jnj-64264681.
Measurable recurring condition in persistent lymphocytic the leukemia disease: expert assessment along with opinion recommendations. 2% and 87.3%, respectively; log-rank p = 0.04. Additionally, clinical abdominal lymph node metastasis (cALNM) independently predicted OS (p = 0.031). After PSM, the OL and HALS groups did not differ significantly in OS (3-year OS rate 80.5% and 89.8%, respectively; log-rank p = 0.716). There was no statistically significant difference in a
Like
Comment
Share
